ReviewCurrent heart failure reports2018
Non-response to Cardiac Resynchronization Therapy.
Review in Current heart failure reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- A New Method of Modeling the Multi-stage Decision-Making Process of CRT Using Machine Learning with Uncertainty Quantification.Journal of imaging informatics in medicine · 2026Article
- Target doses of guideline-directed medical therapeutic agents predicts response to cardiac resynchronization therapy.Clinical research in cardiology : official journal of the German Cardiac Society · 2026Article
- A New Method Using Deep Learning to Predict the Response to Cardiac Resynchronization Therapy.Journal of imaging informatics in medicine · 2025Article
- Early occurrence of heart failure hospitalization or ventricular arrhythmia re-define the long-term prognosis after CRT.ESC heart failure · 2025Article
- A Meta-Analysis of Clinical and Echocardiographic Outcomes of Physiological Versus Conventional Pacing.Biomedicines · 2025Review
- The implementation of speckle tracking echocardiography for cardiac resynchronization therapy optimisation. A rotational myocardial mechanics interpretation.Echo research and practice · 2024Article
- Left bundle branch pacing set to outshine biventricular pacing for cardiac resynchronization therapy?World journal of cardiology · 2024Article
- Add-on Sacubitril/Valsartan Therapy Induces Left Ventricular Remodeling in Non-responders to Cardiac Resynchronization Therapy to a Similar Extent as in Heart Failure Patients Without Resynchronization.Cardiology and therapy · 2024Article
- Clinical Implications of Device-Detected Atrial Fibrillation in Cardiac Resynchronization Therapy.Korean circulation journal · 2023Article
- Feasibility and safety of left bundle branch area pacing-cardiac resynchronization therapy in elderly patients.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2023Article
- First report of super-response after left bundle branch area pacing for cardiac resynchronization therapy utilizing a stylet-driven lead.HeartRhythm case reports · 2022Article
- Success rates, challenges and troubleshooting of left bundle branch area pacing as a cardiac resynchronization therapy for treating patients with heart failure.Frontiers in cardiovascular medicine · 2022Review
- Sacubitril/Valsartan in the Management of Heart Failure Patients with Cardiac Implantable Electronic Devices.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2021Review
- Comparing the Modified Frailty Index with conventional scores for prediction of cardiac resynchronization therapy response in patients with heart failure.Journal of frailty, sarcopenia and falls · 2021Article
- Improvement in quality of life with sacubitril/ /valsartan in cardiac resynchronization non-responders: The RESINA (RESynchronization plus an Inhibitor of Neprilysin/Angiotensin) registry.Cardiology journal · 2021Article
- Combination of Left Ventricular End-Diastolic Diameter and QRS Duration Strongly Predicts Good Response to and Prognosis of Cardiac Resynchronization Therapy.Cardiology research and practice · 2020Article
- Modified frailty as a novel factor in predicting the response to cardiac resynchronization in the elderly population.Clinical interventions in aging · 2019Article
- The interventricular conduction delays guide best cardiac resynchronization therapy: A tailored-patient approach to perform a CRT through Conduction System Pacing.Indian pacing and electrophysiology journalArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewCardiac resynchronization therapy (CRT) is an effective treatment option for therapy-refractory mild to severe heart failure (HF) patients with reduced ejection fraction and left ventricular (LV) conduction delay. Multiple clinical trials have shown that CRT improves cardiac function and overall quality of life, as well as reduces HF hospitalizations, health care costs, and mortality. RECENT
findingsDespite its effectiveness, the "non-response" rate to CRT is around 30%, remaining a major challenge that faces electrophysiologists and researchers. It has been recently suggested that the etiology of CRT non-response is multifactorial, and it requires a multifaceted approach to address it. In this focused review, we will summarize the definitions of CRT non-response, identify key factors for CRT non-response, and offer a simplified framework to address CRT non-response with the main goal of improving CRT outcomes.
Indexed as
Identifiers
30097910What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.